" class="no-js "lang="en-US"> Gustave Roussy - Medtech Alert
Wednesday, July 30, 2025
Gustave Roussy | Pharmtech Focus

Gustave Roussy

About Gustave Roussy

Gustave Roussy

Leading Cancer Centre in Europe, Gustave Roussy is ranked #5 world’s best oncology hospital according to Newsweek magazine and the first one outside the United States. The institute treats patients with all types of cancer at any age and is expert in the treatment of rare and complex tumours.

We place innovation at the heart of a human, scientific and technological revolution in the fight against cancer.

Our physicians and researchers respond to a continuing challenge: deliver patients the fruits of the most recent advances. They devote their energies and their skills to this great challenge: to speed up progress in order to expand the limits of knowledge and offer patients continuing improvements in the specificity of their treatment.

Related Story

Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist

March 25 2022

French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]

Tollys and Gustave Roussy Enter into New Research Agreement

March 7 2022

Tollys, a biopharmaceutical company developing TL-532, the first anti-cancer immunotherapy based on a synthetic toll-like […]